Nivolumab plus chemotherapy or ipilimumab for advanced oesophageal squamous cell carcinoma
Crossref DOI link: https://doi.org/10.1038/s41575-022-00601-1
Published Online: 2022-03-15
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hindson, Jordan
Text and Data Mining valid from 2022-03-15
Version of Record valid from 2022-03-15
Article History
First Online: 15 March 2022